Back to Trades
Viehbacher Christopher
DirectorCIK 0001774478
Profile
- Filings
- 5
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Viehbacher Christopher, Director, has filed 5 SEC reports (2025–2026), spread across 2 companies, totaling $4.9M in disclosed volume. Weighing $1.5M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $1.5M in Braveheart Bio, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Aug 7 | BRVE Braveheart Bio, Inc. | Viehbacher Christopher | Director | Buy | $1.5M |
| Aug 5 | BRVE Braveheart Bio, Inc. | Viehbacher Christopher | Director | Other | $0 |
| Feb 17 | BIIB BIOGEN INC. | Viehbacher Christopher | President and CEO, Director | Award | $0 |
| Feb 10 | BIIB BIOGEN INC. | Viehbacher Christopher | President and CEO, Director | Exercise | $2.2M |
| Dec 3 | BIIB BIOGEN INC. | Viehbacher Christopher | President and CEO, Director | Exercise | $605.2K |
5 filings